Ustekinumab (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Ustekinumab" in Italian language version.

refsWebsite

Global rank Italian rank

4^th place

9^th place

2^nd place

7^th place

799^th place

22^nd place

1landesbioscience.com

low place

low place

399^th place

1,563^rd place

1stelarainfo.com

low place

low place

87^th place

low place

low place

low place

low place

low place

low place

low place

archive.is

Copia archiviata, vol. 23, DOI:10.2165/00063030-200923010-00006, PMID 19344192. URL consultato il 27 aprile 2019 (archiviato dall'url originale il 16 gennaio 2013).

centocor.com

Centocor 12/19/08 Press Release, http://www.centocor.com/centocor/i/press_releases/FDA_ISSUES_COMPLETE_RESPONSE_LETTER_TO_CENTOCOR_FOR_USTEKINUMAB_BIOLOGIC_LICENSE_APPLICATION_

doi.org

dx.doi.org

vol. 1, DOI:10.4161/mabs.1.3.8593, PMID 20069753, http://www.landesbioscience.com/journals/17/article/8593/.
vol. 247, DOI:10.1016/j.cellimm.2007.06.006, PMID 17761156, https://oadoi.org/10.1016/j.cellimm.2007.06.006.
vol. 7, DOI:10.1016/S1474-4422(08)70173-X, PMID 18703004, https://oadoi.org/10.1016/S1474-4422(08)70173-X.
Segal BM, Constantinescu CS, Raychaudhuri A, Kim L, Fidelus-Gort R, Kasper LH, Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study, in Lancet Neurol, vol. 7, n. 9, September 2008, pp. 796–804, DOI:10.1016/S1474-4422(08)70173-X, PMID 18703004.
Copia archiviata, vol. 23, DOI:10.2165/00063030-200923010-00006, PMID 19344192. URL consultato il 27 aprile 2019 (archiviato dall'url originale il 16 gennaio 2013).

drugs.com

Ustekinumab Monograph for Professionals - Drugs.com, su drugs.com.

empr.com

Stelara approved for moderate to severe psoriasis. Sept 2009

idsk.com

news.idsk.com

Medarex to Receive Milestone Payment for Approval of STELARA(TM) (Ustekinumab) for the Treatment of Moderate to Severe Plaque Psoriasis

landesbioscience.com

vol. 1, DOI:10.4161/mabs.1.3.8593, PMID 20069753, http://www.landesbioscience.com/journals/17/article/8593/.

nih.gov

ncbi.nlm.nih.gov

vol. 1, DOI:10.4161/mabs.1.3.8593, PMID 20069753, http://www.landesbioscience.com/journals/17/article/8593/.
vol. 247, DOI:10.1016/j.cellimm.2007.06.006, PMID 17761156, https://oadoi.org/10.1016/j.cellimm.2007.06.006.
vol. 7, DOI:10.1016/S1474-4422(08)70173-X, PMID 18703004, https://oadoi.org/10.1016/S1474-4422(08)70173-X.
Segal BM, Constantinescu CS, Raychaudhuri A, Kim L, Fidelus-Gort R, Kasper LH, Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study, in Lancet Neurol, vol. 7, n. 9, September 2008, pp. 796–804, DOI:10.1016/S1474-4422(08)70173-X, PMID 18703004.
vol. 6, PMID 20421912.
Copia archiviata, vol. 23, DOI:10.2165/00063030-200923010-00006, PMID 19344192. URL consultato il 27 aprile 2019 (archiviato dall'url originale il 16 gennaio 2013).

oadoi.org

vol. 247, DOI:10.1016/j.cellimm.2007.06.006, PMID 17761156, https://oadoi.org/10.1016/j.cellimm.2007.06.006.
vol. 7, DOI:10.1016/S1474-4422(08)70173-X, PMID 18703004, https://oadoi.org/10.1016/S1474-4422(08)70173-X.
Segal BM, Constantinescu CS, Raychaudhuri A, Kim L, Fidelus-Gort R, Kasper LH, Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study, in Lancet Neurol, vol. 7, n. 9, September 2008, pp. 796–804, DOI:10.1016/S1474-4422(08)70173-X, PMID 18703004.

stelarainfo.com

Important Safety Information | STELARA® (ustekinumab), su stelarainfo.com.